Curevac Nv Stock Analysis

CureVac Stock Analysis Notes

About 57.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.61. Some equities with similar Price to Book (P/B) outperform the market in the long run. CureVac NV has Price/Earnings To Growth (PEG) ratio of 0.07. The entity had not issued any dividends in recent years. CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid . The company was founded in 2000 and is headquartered in Tbingen, Germany. Curevac NV operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 764 people. For more info on CureVac NV please contact LLM LLM at 49 7071 9883 0 or go to https://www.curevac.com.

CureVac NV Investment Alerts

CureVac NV Upcoming and Recent Events

CureVac Largest EPS Surprises

View All Earnings Estimates

CureVac NV Environmental, Social, and Governance (ESG) Scores

CureVac Stock Institutional Investors

Note, although CureVac NV's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

CureVac Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.21 B.

CureVac Profitablity

The company has Profit Margin (PM) of 0.35 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of (61.28) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $61.28.

Management Efficiency

CureVac NV has return on total asset (ROA) of 0.1993 % which means that it generated a profit of $0.1993 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.3304 %, meaning that it created $0.3304 on every $100 dollars invested by stockholders. CureVac NV's management efficiency ratios could be used to measure how well CureVac NV manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.22. The current year's Return On Capital Employed is expected to grow to 0.26. At present, CureVac NV's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Intangible Assets is expected to grow to about 13.7 M, whereas Net Tangible Assets are forecasted to decline to about 407.8 M.

Technical Drivers

As of the 21st of July, CureVac NV shows the Downside Deviation of 2.82, risk adjusted performance of 0.1559, and Mean Deviation of 3.11. CureVac NV technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

CureVac NV Price Movement Analysis

CureVac NV Outstanding Bonds

CureVac NV Predictive Daily Indicators

CureVac NV Corporate Filings

CureVac NV Forecast Models

CureVac NV's time-series forecasting models are one of many CureVac NV's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CureVac NV's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how CureVac NV prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling CureVac shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as CureVac NV. By using and applying CureVac Stock analysis, traders can create a robust methodology for identifying CureVac entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. CureVac analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. CureVac analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

CureVac NV stock analysis indicators help investors evaluate how CureVac NV stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading CureVac NV shares will generate the highest return on investment. By understating and applying CureVac NV stock analysis, traders can identify CureVac NV position entry and exit signals to maximize returns.

When running CureVac NV's price analysis, check to measure CureVac NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CureVac NV is operating at the current time. Most of CureVac NV's value examination focuses on studying past and present price action to predict the probability of CureVac NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CureVac NV's price. Additionally, you may evaluate how the addition of CureVac NV to your portfolios can decrease your overall portfolio volatility.